Hypertrophic Cardiomyopathy: History and Future Directions
Image
Course Overview
This webinar will cover the history of hypertrophic cardiomyopathy (HCM), including prevalence data, risk stratification and outcomes. We will explore how to screen for and diagnose the disease. The presentation will include a discussion of treatment options for patients with clinical signs and an exciting new treatment option for subclinical pets.
Learning Objectives
- Describe the prevalence and explain how HCM is diagnosed.
- Understand the lifetime risks of cardiac events in a population of cats with HCM.
- Gain an understanding of treatment options for clinical patients and the mechanism of Felicyn-CA1.
This course was made possible thanks to the generous support of PRN Pharmacal.
Jump to:
Who Should Attend
- ACVIM Diplomates and Candidates
- European affiliate partners Diplomates and Candidates
- Veterinary Technician Specialists (VTS)
CE Credits
RACE Application Status: The on-demand webinar is not offered for RACE CE.
For additional questions, please contact us at Learning@ACVIM.org.